Nectar Lifesciences Ltd (NECT)

Currency in INR
16.48
-0.14(-0.84%)
Closed·
NECT Scorecard
Full Analysis
High shareholder yield
NECT is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
16.1216.98
52 wk Range
15.6156.39
Key Statistics
Bid/Ask
16.50 / 16.79
Prev. Close
16.62
Open
16.62
Day's Range
16.12-16.98
52 wk Range
15.61-56.39
Volume
114.34K
Average Volume (3m)
310.92K
1-Year Change
-48.22%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NECT Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Nectar Lifesciences Ltd Company Profile

Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company’s active pharmaceutical ingredients and intermediates comprise cefixime, cefuroxime axetil amorphous, cefuroxime axetil crystalline, cefotaxime sodium, ceftriaxone sodium, cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil and sterile, cefprozil, cefdinir, cefuroxime sodium, cefazolin sodium, ceftazidime pentahydrate, and cefepime +Arginine. It also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, the company provides menthol and pearl capsules. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.

Employees
1686
Market
India

Compare NECT to Peers and Sector

Metrics to compare
NECT
Peers
Sector
Relationship
P/E Ratio
−3.2x−0.1x−0.5x
PEG Ratio
0.000.050.00
Price/Book
0.4x1.1x2.6x
Price / LTM Sales
0.2x0.6x3.2x
Upside (Analyst Target)
-0.0%41.2%
Fair Value Upside
Unlock9.0%6.2%Unlock

Earnings

Latest Release
Jul 07, 2025
EPS / Forecast
-5.80 / --
Revenue / Forecast
4.31B / --
EPS Revisions
Last 90 days

NECT Income Statement

People Also Watch

201.12
GJIP
+2.25%
486.20
CARD
+0.36%
158.59
TNNP
+0.85%

FAQ

What Stock Exchange Does Nectar Lifesciences Ltd Trade On?

Nectar Lifesciences Ltd is listed and trades on the Bombay Stock Exchange stock exchange.

What Is the Stock Symbol for Nectar Lifesciences Ltd?

The stock symbol for Nectar Lifesciences Ltd is "NECT."

What Is the Nectar Lifesciences Ltd Market Cap?

As of today, Nectar Lifesciences Ltd market cap is 3.69B.

What Is Nectar Lifesciences Ltd's Earnings Per Share (TTM)?

The Nectar Lifesciences Ltd EPS (TTM) is -5.07.

From a Technical Analysis Perspective, Is NECT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nectar Lifesciences Ltd Stock Split?

Nectar Lifesciences Ltd has split 1 times.

How Many Employees Does Nectar Lifesciences Ltd Have?

Nectar Lifesciences Ltd has 1686 employees.

What is the current trading status of Nectar Lifesciences Ltd (NECT)?

As of 29 Jul 2025, Nectar Lifesciences Ltd (NECT) is trading at a price of 16.48, with a previous close of 16.62. The stock has fluctuated within a day range of 16.12 to 16.98, while its 52-week range spans from 15.61 to 56.39.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.